首页> 美国卫生研究院文献>other >Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8
【2h】

Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8

机译:过表达的miR-224通过靶向RASSF8促进宫颈癌的进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cervical cancer is the most common cause of cancer-related deaths in women from developing countries. Identification of novel prognostic predictors or therapeutic targets may improve patient prognosis. In the current study, we demonstrated by real-time PCR that miR-224 expression was significantly upregulated (1.82-fold, P = 0.0025) in cervical cancer tissues (n = 126) compared with in normal cervical tissues (n = 64). Higher expression of miR-224 was significantly associated with poorer prognostic factors, including advanced FIGO stage, nodal metastasis, larger tumor size, vascular involvement and deep stromal invasion (all P < 0.05). Enforced expression of miR-224 promoted cell proliferation, migration and invasion in SiHa and CaSki cancer cell lines. Bioinformatic analysis indicated that RASSF8 (RAS-association domain family 8) was a potential target of miR-224. Western blot analysis and luciferase reporter assay showed that overexpressed miR-224 inhibited RASSF8 protein expression and decreased the activity of a luciferase reporter containing the 3′ untranslated region (UTR) of RASSF8, respectively. Further, RASSF8 knockdown by specific RNAi showed similar effects in cervical cancer cells transfected with miR-224 mimic. Our findings suggest that miR-224 directly targets RASSF8 and thereby acts as a tumor promoter in cervical cancer progression.
机译:宫颈癌是发展中国家女性与癌症相关的死亡的最常见原因。鉴定新的预后预测因子或治疗靶标可改善患者的预后。在当前的研究中,我们通过实时PCR证明,与正常宫颈组织(n = 64)相比,宫颈癌组织(n = 126)中miR-224表达显着上调(1.82倍,P = 0.0025)。 miR-224的高表达与较差的预后因素显着相关,包括预后的FIGO分期,淋巴结转移,较大的肿瘤大小,血管受累和深层基质浸润(所有P <0.05)。 miR-224的强制表达促进了SiHa和CaSki癌细胞系中的细胞增殖,迁移和侵袭。生物信息学分析表明,RASSF8(RAS关联结构域家族8)是miR-224的潜在靶标。 Western印迹分析和荧光素酶报告基因检测结果表明,miR-224的过表达抑制了RASSF8蛋白的表达,并降低了包含RASSF8 3'非翻译区(UTR)的荧光素酶报告基因的活性。此外,通过miRNA-224模拟物转染的宫颈癌细胞在特定RNAi的作用下对RASSF8的抑制作用相似。我们的发现表明,miR-224直接靶向RASSF8,从而在宫颈癌进展中充当肿瘤启动子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号